Effect of blood cholesterol levels on survival of patients with multiple myeloma

DONG Yuehua; LIANG Yan; YAN Huaining

PDF(625 KB)

Medical Journal of the Chinese People Armed Police Forces ›› 2019, Vol. 30 ›› Issue (5) : 420-422.

ORIGINAL ARTICLES

Effect of blood cholesterol levels on survival of patients with multiple myeloma

DONG Yuehua¹, LIANG Yan², YAN Huaining³

Author information +

History +

Abstract

Objective To explore the effects of blood cholesterol levels on the survival of patients with multiple myeloma.Methods One hundred and thirty-six patients with multiple myeloma who were treated in the hospital between June 2014 and September 2017 were selected as the observation group, while another eighty-two healthy physical examinees were selected as the control group. Relevant data was collected and retrospectively analyzed.Results Serum levels of total cholesterol [(2.67±1.12) mmol/L], low-density lipoprotein [(1.62±0.98) mmol/L], apolipoprotein B [(0.45±0.28) mmol/L] and high-density lipoprotein [(0.81±0.28) mmol/L] were significantly lower in the observation group than in the control group (P<0.05). The survival rate of stage Ⅲ patients was significantly lower than that of stage Ⅰ and stage Ⅱ patients (P<0.05). Low-density lipoprotein levels [(1.38±0.56) mmol/L] were the lowest in patients with IgA multiple myeloma, but [(2.25±0.43) mmol/L] were the highest in patients with light-chain multiple myeloma (P<0.05).Conclusion The development and survival of multiple myeloma are closely related to blood cholesterol levels that depend on the intake of low-density lipoprotein. Low blood cholesterol levels can lead to the deterioration of a patient’s condition and drug resistance, which negatively affects patients’ survival and quality of life.

Key words

blood cholesterol / multiple myeloma / low density lipoprotein / survival status

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations

DONG Yuehua, LIANG Yan, YAN Huaining. Effect of blood cholesterol levels on survival of patients with multiple myeloma[J]. Medical Journal of the Chinese People Armed Police Forces. 2019, 30(5): 420-422

References

[1] 马丛丛,刘彦琴.多发性骨髓瘤患者血脂水平的变化及其临床意义[J].实用临床医药杂志,2014,23 (7):113-115.
[2] 古流芳,崔晓光,何爱丽,等.多发性骨髓瘤低胆固醇血症与预后相关性分析及机制[J].兰州大学学报(医学版),2018,44(1):48-52.
[3] 克依木江·吾卜力卡司木,吐尔逊江·司拉木,阿地拉·苏力坦,等.多发性骨髓瘤患者血脂与血清α1-酸性糖蛋白检测的意义[J].现代检验医学杂志,2015,30(5):168-169.
[4] 何伶俐,柯勇.多发性骨髓瘤患者HBsAg检测及HBV感染的风险研究[J].中国实验血液学杂志,2017, 25(6):1718-1721.
[5] 卢静,杜鹃,傅卫军,等.修订的国际分期系统(R-ISS)在初诊多发性骨髓瘤患者预后判断中的意义[J].中华血液学杂志,2017,38(6):475-479.
[6] Hutchinson A T,Malik A,Berkahn M B,et al.Formation of assemblies on cell membranes by secreted proteins: molecular studies of free light chain aggregates found on the surface of myeloma cells[J]. Biochemical J,2013,454(3):479-489.
[7] 王双玲,刘峰,陈江声,等.多发性骨髓瘤患者肺部感染的临床特点及相关因素分析[J].中国感染与化疗杂志,2017,17(3):253-255.
[8] 金晓娜,周宝珍,张党锋,等.多发性骨髓瘤患者VEGF、IL-17、β₂-MG、IL-35表达水平及临床意义[J].中国实验血液学杂志,2018,26(1):192-196.
[9] Yang C,He X,Chen J,et al.Fe₃O₄ nanoparticle loaded paclitaxel induce multiple myeloma apoptosis by cell cycle arrest and increase cleavage of caspases in vitro[J].J Nanopart Res,2013,15(8):18401-18413.
[10] 高鹏,肖中平,付堃,等.血小板平均体积测定在多发性骨髓瘤中的临床意义[J].中国实验血液学杂志,2017,25(3):827-831.
[11] Dutoit J C,Vanderkerken M A,Verstraete K L, et al.Value of whole body MRI and dynamic contrast enhanced MRI in the diagnosis, follow-up and evaluation of disease activity and extent in multiple myeloma[J].Eur J Radiol,2013,82(9):1444-1452.
[12] 王蕾,李艳.多发性骨髓瘤侧群细胞的研究进展[J].中国实验血液学杂志,2017,25(4):1250-1254.
[13] Tarek B,Daniel C,Elodie F,et al.Plasma cells release membrane microparticles in a mouse model of multiple myeloma[J]. Int J Microscopy,2013,54:75-81.
[14] 王路,张翼鷟.伴髓外病变的多发性骨髓瘤研究进展[J].中国实验血液学杂志,2016,24(3): 945-948.
[15] Tageja N,Manasanch E E,Korde N, et al.Smoldering multiple myeloma: present position and potential promises[J]. Eur J Haematol,2014,92(1):1-12.